Online Forums

Health Outcomes Observatory (H2O) with Meni Styliadou, H2O Founder and Co-Leader, Distinguished Fellow of the Data Sciences Institute and VP of Government Affairs, Public Policy, and Sustainable Healthcare at Takeda.

In conversation with Francesco Patalano, H2O Working Group Leader and Head of Pediatric and Patient Reported Outcomes Centers of Excellence at Novartis, and Madeleine Brady, H2O Communications (Moderator).

20+ Years of Sustainability Leadership – A conversation with Lars Rebien Sørensen

Continuing the dialog between biopharma leaders and capital markets representatives on how to structure effective, efficient, and decision-useful communications about ESG strategy and performance.

Towards a global perspective on Biopharma sustainability, hosted by the ESG Disclosure Study Group, Japan.

Update on global hard and soft regulatory changes affecting biopharma.
Focus on EU: Green Deal, Circular Economy, Sustainable Finance, Non-Financial Reporting Directive.
Speaker: Olivier Jaeggi, Managing Director, ECO:FACT

Roundtable Forum with Lise Kingo.
Biopharma sustainability oversight and governance priorities.
Speaker: Lise Kingo, Independent Director, Sanofi; former Executive Director, UN Global Compact

Connecting Biopharma Sustainability and Long-Term Planning — A collaboration with CECP’s CEO Investor Forum. Initial release of our Executive Report and Practitioner’s Guide for integrating sustainability and long-term planning for biopharma companies.

A direct conversation between Biopharma sustainability leaders and sector investors about metrics for the sector’s highest-priority ESG topics.

First look at a new sector initiative focused on collective downstream product stewardship.